Disopyramide and Nirmatrelvir: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Disopyramide
Nirmatrelvir
No brand names on recordHow we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Increased disopyramide exposure and potential toxicity (anticholinergic effects, hypotension, heart failure, cardiac arrhythmias)
Interaction Deep Dive
Caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics such as disopyramide when coadministered with nirmatrelvir/ritonavir1. Use of alternate COVID-19 treatment is suggested, as the risk generally outweighs the benefit of coadministration 2.
Why it happens (mechanism)
Inhibition of CYP3A-mediated metabolism of disopyramide
Common questions
Can I take Disopyramide and Nirmatrelvir together?
Increased disopyramide exposure and potential toxicity (anticholinergic effects, hypotension, heart failure, cardiac arrhythmias) Always confirm with your pharmacist or prescriber before making any change.
How serious is the Disopyramide and Nirmatrelvir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Questions for your pharmacist
- Does my dose of Disopyramide or Nirmatrelvir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: PAXLOVID(TM) oral tablets, nirmatrelvir oral tablets, ritonavir oral tablets. Pfizer Labs (per FDA), New York, NY, 2023. DailyMed
- COVID-19 Treatment Guidelines Panel: Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health (NIH). Bethesda, MD. 2023.
Keep reading about Disopyramide
Keep reading about Nirmatrelvir
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist